KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Inventory (2016 - 2025)

Globus Medical's Inventory history spans 15 years, with the latest figure at $759.3 million for Q4 2025.

  • For Q4 2025, Inventory rose 15.18% year-over-year to $759.3 million; the TTM value through Dec 2025 reached $759.3 million, up 15.18%, while the annual FY2025 figure was $759.3 million, 15.18% up from the prior year.
  • Inventory reached $759.3 million in Q4 2025 per GMED's latest filing, down from $771.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $905.0 million in Q3 2023 to a low of $231.2 million in Q2 2021.
  • Average Inventory over 5 years is $518.8 million, with a median of $497.4 million recorded in 2023.
  • Peak YoY movement for Inventory: surged 220.45% in 2023, then dropped 22.27% in 2024.
  • A 5-year view of Inventory shows it stood at $237.0 million in 2021, then rose by 26.15% to $299.0 million in 2022, then surged by 183.68% to $848.1 million in 2023, then decreased by 22.27% to $659.2 million in 2024, then grew by 15.18% to $759.3 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Inventory are $759.3 million (Q4 2025), $771.5 million (Q3 2025), and $772.1 million (Q2 2025).